Skip Navigation

Annals for Hospitalists

Michigan Medicine

If you practice hospital medicine, Annals for Hospitalists simplifies your search for information that matters most to you. Developed with the Division of Hospital Medicine at Michigan Medicine and the VA Ann Arbor Health System, Annals for Hospitalists provides monthly highlights from Annals of Internal Medicine and ACP Journal Club and “Inpatient Notes”—unique perspectives on contemporary topics in hospital medicine.

Feature Editors:
David H. Wesorick, MD, Assistant Professor, Internal Medicine
Vineet Chopra, MD, MSc, Assistant Professor, Internal Medicine
Full Biographies

18 FEBRUARY 2020

Inpatient Notes

Annals for Hospitalists Inpatient Notes - Optimizing Inpatient Nutrition—Why Hospitalists Should Get Involved
—Philipp Schuetz, MD, MPH, and Jeffrey L. Greenwald, MD

In this month's commentary, the authors explain how emerging evidence is changing the way hospitalists think about inpatient nutritional assessment and support.

Highlights of Recent Articles from Annals of Internal Medicine

Originally published for the broader Annals audience, these articles feature subjects most relevant to hospitalists.

Cost-Effectiveness of Transitional Care Services After Hospitalization With Heart Failure

Ann Intern Med. 2020;172:248-257. Published 28 January 2020. doi:10.7326/M19-1980

Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study

Ann Intern Med. Published 7 January 2020. doi:10.7326/M19-0080.

Who Owns Sepsis?

Ann Intern Med. 2020;172:210-211. Published 28 January 2020. doi:10.7326/M19-2966

Read Summaries and Key Points for Hospitalists

The Latest Highlights From Journal Club

ACP Journal Club is a monthly feature in Annals of Internal Medicine that contains editorial, easy-to-read abstracts pulled from 130 leading medical journals.

ASCO updated recommendations for preventing and treating VTE in adults with cancer

Ann Intern Med. 2020;172:JC2. doi: 10.7326/ACPJ202001210-002

In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet

Ann Intern Med. 2020;172:JC2. doi: 10.7326/ACPJ202001210-006

Read Summaries and Key Points for Hospitalists
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×